thalassemia

Showing 1 - 25 of 104

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cognitive Function and Quality of Life in Thalassemic Children

Not yet recruiting
  • Thalassemia
  • Pediatric Quality of Life Inventory (questionnaire) and The Stanford-Binet Intelligence Scale fifth edition
  • Sohag, Egypt
    Sohag university Hospital
Sep 25, 2023

Quality of Life in Thalassemic Patients at Assiut University

Not yet recruiting
  • Thalassemia
  • Abdominal ultrasound
  • (no location specified)
Mar 17, 2023

Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)

Recruiting
  • Sickle Cell Disease
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Feb 17, 2023

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)

Recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Nashville, Tennessee
  • +5 more
Feb 2, 2023

Thalassemia Trial in Canada, United Kingdom, United States (AG-348)

Active, not recruiting
  • Thalassemia
  • Oakland, California
  • +3 more
Jan 26, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023

Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

Active, not recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Stanford, California
  • +11 more
Nov 30, 2022

A Long-term Follow-up Study in Subjects Who Received CTX001

Enrolling by invitation
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • New York, New York
  • +12 more
Nov 18, 2022

Atrial Fibrillation in Beta-Thalassemia

Not yet recruiting
  • Atrial Fibrillation
  • Thalassemia
    • Ferrara, Italy
      Matteo Bertini
    Aug 18, 2022

    Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))

    Active, not recruiting
    • Thalassemia
    • Los Angeles, California
    • +16 more
    Aug 16, 2022

    Thalassemia, Iron Overload Trial in Nanning (CN128 Tablets)

    Recruiting
    • Thalassemia
    • Iron Overload
    • CN128 Tablets
    • Nanning, Guangxi, China
      The First Affiliated Hospital Of Guangxi Medical University
    Aug 3, 2022

    Thalassemia, Iron Overload Trial in Nanning (CN128 Tablets)

    Active, not recruiting
    • Thalassemia
    • Iron Overload
    • CN128 Tablets
    • Nanning, Guangxi, China
      The First Affiliated Hospital Of Guangxi Medical University
    Aug 3, 2022

    Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

    Not yet recruiting
    • Beta-Thalassemia
    • +6 more
    • CTX001
    • (no location specified)
    Jul 26, 2022

    Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

    Recruiting
    • Sickle Cell Disease
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jul 6, 2022

    Hemoglobinopathies, Thalassemia, Sickle Cell Disease Trial in Banha (Hemoglobinopathy Nursing Program)

    Completed
    • Hemoglobinopathies
    • +3 more
    • Hemoglobinopathy Nursing Program
    • Banhā, Other, Egypt
      Benha University
    May 21, 2022

    Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders Trial in Minneapolis (Blood and Marrow Transplant)

    Recruiting
    • Sickle Cell Disease
    • +4 more
    • Blood and Marrow Transplant
    • Minneapolis, Minnesota
      Masonic Caner Center at University of Minnesota
    May 23, 2022

    Thalassemia, Iron Overload Trial in Salaya (Meal matrix with polyphenol supplement (PPS), Meal matrix with , No meal matrix with

    Not yet recruiting
    • Thalassemia
    • Iron Overload
    • Meal matrix with polyphenol supplement (PPS)
    • +3 more
    • Salaya, Thailand
      Mahidol University
    Apr 13, 2022

    Thalassemia Trial in Peshawar (Thalidomide and Hydroxyurea)

    Completed
    • Thalassemia
    • Thalidomide and Hydroxyurea
    • Peshawar, Khyber Pakhtukhwa, Pakistan
      Blood Diseases Clinic
    Mar 10, 2022

    Red Blood Cell - IMProving trAnsfusions for Chronically

    Recruiting
    • Sickle Cell Disease
    • +2 more
    • Red Blood Cell (RBC) Transfusion
    • Oakland, California
    • +13 more
    Mar 18, 2022

    Sickle Cell Disease, Thalassemia Trial in Memphis (Hydroxyurea, Hydroxyurea Oral Capsule)

    Terminated
    • Sickle Cell Disease
    • Thalassemia
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Feb 18, 2022

    Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem

    Active, not recruiting
    • Hematologic Malignancies
    • +7 more
    • San Francisco, California
      University of California, San Francisco
    Feb 28, 2022

    Clofarabine and Fludarabine Drug Exposure in Pediatric Bone

    Completed
    • Hematologic Malignancies
    • +7 more
    • San Francisco, California
      University of California, San Francisco
    Sep 27, 2021

    Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell

    Completed
    • Hematologic Malignancies
    • +7 more
    • San Francisco, California
      University of California, San Francisco
    Sep 27, 2021

    Fludarabine Drug Exposure in Pediatric Bone Marrow

    Completed
    • Hematologic Malignancies
    • +7 more
    • San Francisco, California
      University of California, San Francisco
    Sep 27, 2021